Bone metabolism and body composition in Japanese patients with active acromegaly

Clinical Endocrinology

Volumn 55, Issue 2, 2001, Pages 175-181

  Kaji, Hiroshi ^a   Sugimoto, Toshitsugu ^a   Nakaoka, Daiki ^a   Okimura, Yasuhiko ^a   Kaji, Hidesuke ^a   Abe, Hiromi ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; FAT; GROWTH HORMONE; OSTEOCALCIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3;

ACROMEGALY; ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; JAPAN; LEAN BODY WEIGHT; LUMBAR SPINE; MALE; MASS; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIUS; REGULATORY MECHANISM; URINE LEVEL;

ABSORPTIOMETRY, PHOTON; ACROMEGALY; AMINO ACIDS; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; COLLAGEN; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS;

EID: 0034828791     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01280.x     Document Type: Article

References (42)

1. Skeletal metabolism and body composition in acromegaly
2. Body composition in acromegaly
3. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone response to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3
4. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
5. Immunoassay for quantifying type I collagen degradation products in urine evaluated
6. Human growth hormone and human aging
7. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
8. Clinical aspects of growth hormone deficiency in adults
9. Spinal and peripheral bone mineral densities in acromegaly: The effects of excess growth hormone and hypogonadism
10. Biochemical assessment of bone formation and resorption in acromegaly
11. Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states
12. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
13. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
14. Characteristics of the human lymphocyte insulin receptor
15. In vitro actions of growth hormone on glucose metabolism in adipose tissue
16. Altered profiles of biological activity of growth hormone fragments on adipocyte metabolism
17. Urinary hydroxyproline excretion in acromegaly
18. Iliac crest bone mass and remodeling in acromegaly
19. Assay of serum pyridinoline: A potent marker for bone resorption
20. Bone mineral density of the axial skeleton in acromegaly
21. Bone density of the lumbar spine and femur in acromegaly
22. Clinical review 61; effects of growth hormone on human bone biology
23. Insulin-like growth factor I stimulates bone turnover in osteoporosis
24. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men
25. Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies
26. Bone mineral density and parameters of bone metabolism in patients with acromegaly
27. Gonadal status is an important determinant of bone density in acromegaly
28. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH defficiency
29. Growth hormone and bone
30. Body composition and energy expenditure in acromegaly
31. Growth hormone and adult bone remodeling
32. Insulin-like growth factor I (IGF-I) affects plasma lipid profile and inhibits the lipolytic action of growth hormone (GH) in isolated adipocytes
33. Insulin-like growth factors and bone: The osteoporosis connection
34. Effects of human growth hormone in men over 60 years old
35. Skeletal involvement in female acromegalic subjects: The effects of growth hormone excess in amenorrheal and menstruating patients
36. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status
37. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats
38. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
39. Age-dependent changes in body composition in postmenopausal Japanese women: Relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
40. Effect of recombinant human growth hormone in elderly osteoporotic women
41. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: Effects of long-term octreotide treatment
42. Effect of menopause and hormone replacemnet therapy on the urinary excretion of pyridinium cross-links